Michael Deuschle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael Deuschle has a total of 368 co-authors. Here are the top co-authors by number of shared publications:
- Maria Gilles
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim / Heidelberg University, Mannheim, Germany
11 shared publications - Marcella Rietschel
Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
9 shared publications - Stephanie H. Witt
Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
8 shared publications - Fabian Streit
Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
6 shared publications - Helene Dukal
Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
6 shared publications - Josef Frank
Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
6 shared publications
Latest Publications
- 8 October 2026
- Published by Springer Nature
- p. 155-167
Mental Health First Aid am Arbeitsplatz: Frühintervention, Entstigmatisierung und Evidenz der Wirksamkeit
- 8 October 2026
- Published by Springer Nature
- p. 155-167
Mental Health First Aid am Arbeitsplatz: Frühintervention, Entstigmatisierung und Evidenz der Wirksamkeit
- Open Access
- 20 July 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (8) , 1831-1844
Genome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders
Borderline personality disorder (BPD) is a severe mental health condition influenced by environmental risk factors (for example, interpersonal trauma) and genetic factors. We conducted the largest genome-wide association study (GWAS) meta-analysis of BPD so far, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci and 9 risk genes in gene-based analyses. We observed a single-nucleotide polymorphism heritability of 17.3% and derived polygenic scores (PGS) that predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of post-traumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide analyses in Vanderbilt University Medical Center Biobank and UK Biobank using BPD-PGS confirmed these associations and also identified associations with other medical conditions, including obstructive pulmonary disease and diabetes. These analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
- 20 July 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (8) , 1831-1844
Open AccessGenome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders
Borderline personality disorder (BPD) is a severe mental health condition influenced by environmental risk factors (for example, interpersonal trauma) and genetic factors. We conducted the largest genome-wide association study (GWAS) meta-analysis of BPD so far, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci and 9 risk genes in gene-based analyses. We observed a single-nucleotide polymorphism heritability of 17.3% and derived polygenic scores (PGS) that predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of post-traumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide analyses in Vanderbilt University Medical Center Biobank and UK Biobank using BPD-PGS confirmed these associations and also identified associations with other medical conditions, including obstructive pulmonary disease and diabetes. These analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
- 2 July 2026
- Published by Springer Nature
- p. 607-617
Psychokardiologie
- Open Access
- 15 January 2026
- Published by Springer Nature in Der Nervenarzt
- Vol. 97 (1) , 42-43
Einführung zum Thema: Psychokardiologie – Perspektive für Lebensqualität und Lebenserwartung
- 15 January 2026
- Published by Springer Nature in Der Nervenarzt
- Vol. 97 (1) , 42-43
Open AccessEinführung zum Thema: Psychokardiologie – Perspektive für Lebensqualität und Lebenserwartung
- Open Access
- 27 October 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , 1-25
Initial effects of Mental Health First Aid training on mental health literacy, social distance, stigma, mental health, and quality of life in the German adult population – Findings from a pilot study
Background: Despite the high prevalence of mental disorders, knowledge about mental health, its promotion, prevention, and pathways to care in the general population remain limited. Mental Health First Aid (MHFA) seeks to increase mental health literacy in the general population and enable individuals to support others with mental health problems until professional help is available. This study aimed to investigate the feasibility and initial effects of MHFA training on (i) mental health literacy, (ii) stigmatizing attitudes toward individuals with mental health problems, (iii) social distance, (iv) trainees’ mental health, and (v) quality of life. Methods: In an uncontrolled pilot study, individuals aged 18–75 years who participated in MHFA courses in Germany were recruited. Outcomes were assessed at baseline, post-training, and 6-month follow-up. Results: In total, 362 participants (mean age 43 years, 78% female) enrolled in the study at baseline. Retention was about 50% for post-training and 60% for follow-up assessment. At post-training, mental health literacy was increased ( adj Β = 6.77, 95% CI = 5.69 to 7.84) and social distance ( adj Β = −2.30, 95% CI = −2.73 to −1.87) and stigmatizing attitudes ( adj Β = −2.61, 95% CI = −3.25 to −1.97) were reduced. These effects were also evident at 6-month follow-up. There were no effects on trainees’ mental health. At the 6-month follow-up, 89% of trainees had talked to someone with mental health problems at least once, and 65% of trainees were quite or very confident in offering help. Conclusions: Our findings suggest initial beneficial effects of MHFA training as implemented in Germany. A randomized controlled trial of MHFA in Germany is now warranted.
- 27 October 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , 1-25
Open AccessInitial effects of Mental Health First Aid training on mental health literacy, social distance, stigma, mental health, and quality of life in the German adult population – Findings from a pilot study
Background: Despite the high prevalence of mental disorders, knowledge about mental health, its promotion, prevention, and pathways to care in the general population remain limited. Mental Health First Aid (MHFA) seeks to increase mental health literacy in the general population and enable individuals to support others with mental health problems until professional help is available. This study aimed to investigate the feasibility and initial effects of MHFA training on (i) mental health literacy, (ii) stigmatizing attitudes toward individuals with mental health problems, (iii) social distance, (iv) trainees’ mental health, and (v) quality of life. Methods: In an uncontrolled pilot study, individuals aged 18–75 years who participated in MHFA courses in Germany were recruited. Outcomes were assessed at baseline, post-training, and 6-month follow-up. Results: In total, 362 participants (mean age 43 years, 78% female) enrolled in the study at baseline. Retention was about 50% for post-training and 60% for follow-up assessment. At post-training, mental health literacy was increased ( adj Β = 6.77, 95% CI = 5.69 to 7.84) and social distance ( adj Β = −2.30, 95% CI = −2.73 to −1.87) and stigmatizing attitudes ( adj Β = −2.61, 95% CI = −3.25 to −1.97) were reduced. These effects were also evident at 6-month follow-up. There were no effects on trainees’ mental health. At the 6-month follow-up, 89% of trainees had talked to someone with mental health problems at least once, and 65% of trainees were quite or very confident in offering help. Conclusions: Our findings suggest initial beneficial effects of MHFA training as implemented in Germany. A randomized controlled trial of MHFA in Germany is now warranted.
- Open Access
Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders
We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
Open AccessGenome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders
We conducted the largest genome-wide meta-analysis of borderline personality disorder (BPD) to date, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls (all participants of European ancestry). We identified 11 independent associated genomic loci, and nine risk genes in the gene-based analysis. We observed a single-nucleotide polymorphism (SNP) heritability of 17.3% and derived polygenic scores (PGS) predicted 4.6% of the phenotypic variance in BPD on the liability scale. BPD showed the strongest positive genetic correlations with GWAS of posttraumatic stress disorder, depression, attention deficit hyperactivity disorder, antisocial behavior, and measures of suicide and self-harm. Phenome-wide association analyses using BPD-PGS confirmed these associations and additionally revealed associations with general medical conditions including obstructive pulmonary disease and diabetes. The present analyses highlight BPD as a polygenic disorder, with the genetic risk showing substantial overlap with psychiatric and physical health conditions.
- Open Access
- 27 August 2024
- Published by Springer Nature in Annals of General Psychiatry
- Vol. 23 (1) , 1-17
Association between rTMS-induced changes in inflammatory markers and improvement in psychiatric diseases: a systematic review
Repetitive transcranial magnetic stimulation (rTMS) has recently gained relevance in treating different psychiatric disorders. Limited evidence suggests that the beneficial effects of rTMS on psychopathology could be at least partly mediated through changes in inflammatory response. This systematic review summarizes the literature on whether rTMS can modulate inflammatory markers and thus positively influence the course of psychiatric illnesses. A systematic review of rTMS and inflammatory markers in psychiatric diseases was conducted according to PRISMA guidelines. Information on the association between rTMS treatment response and changes of inflammatory markers was extracted. The quality of the studies was assessed using the National Heart, Lung, and Blood Institute for human studies and the Systematic Review Center for Laboratory Animal Experimentation for animal studies. This review includes 17 studies (2 animal and 15 human studies) on the relationship between rTMS treatment response and changes of inflammatory markers. Positive changes in microglial activity and anti-inflammatory effects were associated with behavioral improvement in animal models of depression. However, these findings have not been consistently replicated in human studies focusing on treatment-resistant depression. While several studies reported rTMS-induced alterations in peripheral inflammatory markers, only two could demonstrate their association to clinical treatment response. Notably, most studies showed poor or moderate quality in the bias assessment. While certain human studies suggest an association between rTMS-induced anti-inflammatory effects and improvement in psychopathology, heterogeneity, and underpowered analyses constrain the generalizability of these results. The discrepancy between animal and human findings highlights the need for larger, standardized human studies. (PROSPERO Registration: CRD42023492732).
- 27 August 2024
- Published by Springer Nature in Annals of General Psychiatry
- Vol. 23 (1) , 1-17
Open AccessAssociation between rTMS-induced changes in inflammatory markers and improvement in psychiatric diseases: a systematic review
Repetitive transcranial magnetic stimulation (rTMS) has recently gained relevance in treating different psychiatric disorders. Limited evidence suggests that the beneficial effects of rTMS on psychopathology could be at least partly mediated through changes in inflammatory response. This systematic review summarizes the literature on whether rTMS can modulate inflammatory markers and thus positively influence the course of psychiatric illnesses. A systematic review of rTMS and inflammatory markers in psychiatric diseases was conducted according to PRISMA guidelines. Information on the association between rTMS treatment response and changes of inflammatory markers was extracted. The quality of the studies was assessed using the National Heart, Lung, and Blood Institute for human studies and the Systematic Review Center for Laboratory Animal Experimentation for animal studies. This review includes 17 studies (2 animal and 15 human studies) on the relationship between rTMS treatment response and changes of inflammatory markers. Positive changes in microglial activity and anti-inflammatory effects were associated with behavioral improvement in animal models of depression. However, these findings have not been consistently replicated in human studies focusing on treatment-resistant depression. While several studies reported rTMS-induced alterations in peripheral inflammatory markers, only two could demonstrate their association to clinical treatment response. Notably, most studies showed poor or moderate quality in the bias assessment. While certain human studies suggest an association between rTMS-induced anti-inflammatory effects and improvement in psychopathology, heterogeneity, and underpowered analyses constrain the generalizability of these results. The discrepancy between animal and human findings highlights the need for larger, standardized human studies. (PROSPERO Registration: CRD42023492732).
- 27 March 2024
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 165, 107035
Stress during pregnancy and fetal serum BDNF in cord blood at birth
- 27 March 2024
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 165, 107035
Stress during pregnancy and fetal serum BDNF in cord blood at birth
- Open Access
- 6 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Effects of left anodal transcranial direct current stimulation on hypothalamic–pituitary–adrenal axis activity in depression: a randomized controlled pilot trial
The main objective of this study was to evaluate the effect of left anodal transcranial direct current stimulation (tDCS) on hypothalamic–pituitary–adrenal axis (HPAA) activity in individuals with depression. We conducted a 3-week, randomized, triple-blind pilot trial with 47 participants (dropout rate: 14.89%) randomly assigned to either the tDCS or control group (sham stimulation). Salivary cortisol was used as an HPAA activity marker since cortisol is the effector hormone of the HPAA. The primary outcome was the effect of tDCS on the diurnal cortisol pattern (DCP and area under the curve with respect to ground -AUCg-). Secondary outcomes included tDCS effects on cortisol awakening response (CAR) and cortisol decline (CD), as well as the variation of cortisol concentrations between the initiation of tDCS and 2 weeks later. Intention-to-treat and per-protocol analyses were conducted. Our primary outcome showed an absent effect of tDCS on DCP and AUCg. Additionally, tDCS had an absent effect on CAR, CD, and cortisol concentration variation before-after stimulation. Our pilot study suggests that anodal tDCS showed an absent effect on HPAA activity in individuals with depression. More studies are needed to confirm these findings.
- 6 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Open AccessEffects of left anodal transcranial direct current stimulation on hypothalamic–pituitary–adrenal axis activity in depression: a randomized controlled pilot trial
The main objective of this study was to evaluate the effect of left anodal transcranial direct current stimulation (tDCS) on hypothalamic–pituitary–adrenal axis (HPAA) activity in individuals with depression. We conducted a 3-week, randomized, triple-blind pilot trial with 47 participants (dropout rate: 14.89%) randomly assigned to either the tDCS or control group (sham stimulation). Salivary cortisol was used as an HPAA activity marker since cortisol is the effector hormone of the HPAA. The primary outcome was the effect of tDCS on the diurnal cortisol pattern (DCP and area under the curve with respect to ground -AUCg-). Secondary outcomes included tDCS effects on cortisol awakening response (CAR) and cortisol decline (CD), as well as the variation of cortisol concentrations between the initiation of tDCS and 2 weeks later. Intention-to-treat and per-protocol analyses were conducted. Our primary outcome showed an absent effect of tDCS on DCP and AUCg. Additionally, tDCS had an absent effect on CAR, CD, and cortisol concentration variation before-after stimulation. Our pilot study suggests that anodal tDCS showed an absent effect on HPAA activity in individuals with depression. More studies are needed to confirm these findings.
- Open Access
- 2 August 2022
- Published by Springer Nature in Research Square
Effect of left anodal transcranial direct current stimulation on hypothalamic-pituitary-adrenal axis (HPAA) activity in patients with depressive episodes: a randomized, triple-blind, pilot trial
Background This study's main aim was to evaluate the effect of left anodal transcranial direct current stimulation (tDCS) on hypothalamic-pituitary-adrenal axis (HPAA) activity in participants with depression. As an additional exploratory objective, we aimed to find any relationship between baseline morning cortisol concentrations, family history of depression, and somatic symptoms. Materials and Methods A 3-week, randomized, triple-blind, pilot trial was carried out. Participants (n = 47, drop-out: 14.89%) were allocated randomly to one of two groups: tDCS and control group (sham stimulation). Since the effector hormone of the HPAA is cortisol, salivary cortisol was used as an HPAA activity marker. The primary outcome was the effect of tDCS on the diurnal cortisol pattern (DCP). Secondary outcomes were tDCS effects on cortisol awakening response (CAR) and maximal cortisol decline (MCD), as well as the variation of cortisol concentrations between the initiation of tDCS and 2 weeks later. Intention-to-treat and per-protocol analyses were carried out. Results Regarding our primary outcome, we found no significant effectof tDCS on the interaction group * time * daytime. Concerning our secondary outcomes, tDCS had no significant effects on CAR, MCD or cortisol concentration variation between the initiation of tDCS and 2 weeks later in the tDCS group when compared with the sham stimulation group. Finally, an exploratory analysis found a significant relationship between morning cortisol, family history of depression, and somatic symptoms. Conclusions Our main results indicate that anodal tDCS did not affect HPAA activity in depression. More studies are needed to confirm these findings.
- 2 August 2022
- Published by Springer Nature in Research Square
Open AccessEffect of left anodal transcranial direct current stimulation on hypothalamic-pituitary-adrenal axis (HPAA) activity in patients with depressive episodes: a randomized, triple-blind, pilot trial
Background This study's main aim was to evaluate the effect of left anodal transcranial direct current stimulation (tDCS) on hypothalamic-pituitary-adrenal axis (HPAA) activity in participants with depression. As an additional exploratory objective, we aimed to find any relationship between baseline morning cortisol concentrations, family history of depression, and somatic symptoms. Materials and Methods A 3-week, randomized, triple-blind, pilot trial was carried out. Participants (n = 47, drop-out: 14.89%) were allocated randomly to one of two groups: tDCS and control group (sham stimulation). Since the effector hormone of the HPAA is cortisol, salivary cortisol was used as an HPAA activity marker. The primary outcome was the effect of tDCS on the diurnal cortisol pattern (DCP). Secondary outcomes were tDCS effects on cortisol awakening response (CAR) and maximal cortisol decline (MCD), as well as the variation of cortisol concentrations between the initiation of tDCS and 2 weeks later. Intention-to-treat and per-protocol analyses were carried out. Results Regarding our primary outcome, we found no significant effectof tDCS on the interaction group * time * daytime. Concerning our secondary outcomes, tDCS had no significant effects on CAR, MCD or cortisol concentration variation between the initiation of tDCS and 2 weeks later in the tDCS group when compared with the sham stimulation group. Finally, an exploratory analysis found a significant relationship between morning cortisol, family history of depression, and somatic symptoms. Conclusions Our main results indicate that anodal tDCS did not affect HPAA activity in depression. More studies are needed to confirm these findings.